Technical Analysis for HTGM - HTG Molecular Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 0.77 -3.75% -0.03
HTGM closed down 3.75 percent on Friday, September 20, 2019, on 8.35 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical HTGM trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Gilligan's Island Buy Setup Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Narrow Range Bar Range Contraction -3.75%
NR7 Range Contraction -3.75%
NR7-2 Range Contraction -3.75%
Oversold Stochastic Weakness -8.42%

Older signals for HTGM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
HTG Molecular Diagnostics, Inc. develops and markets a technology platform that facilitates the routine use of complex molecular profiling. The company's HTG Edge platform consists of instrumentation, consumables, and software analytics that are used in sample profiling applications, including tumor profiling, molecular diagnostic testing, and biomarker development. The HTG Edge platform automates the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology comprising HTG Edge Immuno-oncology Assay, HTG Edge FGFR Expression Assay, HTG Edge DLBCL Cell of Origin Assay, HTG EdgeSeq microRNA Whole-transcriptome Assay, HTG Edge Top Oncogene Assay, and HTG Edge DMPK Assay. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States; and through distributors or sales agents in parts of Europe, India, and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Medicine Biotechnology Biology Nature Tumor Drug Development Molecular Diagnostics Edge Assay Biomarker Microrna
Is HTGM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 5.46
52 Week Low 0.68
Average Volume 247,640
200-Day Moving Average 2.0602
50-Day Moving Average 1.1032
20-Day Moving Average 0.8593
10-Day Moving Average 0.8129
Average True Range 0.0746
ADX 37.77
+DI 11.6366
-DI 34.4589
Chandelier Exit (Long, 3 ATRs ) 0.8162
Chandelier Exit (Short, 3 ATRs ) 0.9038
Upper Bollinger Band 0.9807
Lower Bollinger Band 0.7379
Percent B (%b) 0.13
BandWidth 28.255557
MACD Line -0.0904
MACD Signal Line -0.1027
MACD Histogram 0.0123
Fundamentals Value
Market Cap 8.81 Million
Num Shares 11.4 Million
EPS -2.95
Price-to-Earnings (P/E) Ratio -0.26
Price-to-Sales 5.18
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.91
Resistance 3 (R3) 0.89 0.83 0.88
Resistance 2 (R2) 0.83 0.80 0.84 0.87
Resistance 1 (R1) 0.80 0.77 0.82 0.82 0.87
Pivot Point 0.74 0.74 0.75 0.75 0.74
Support 1 (S1) 0.71 0.71 0.73 0.73 0.67
Support 2 (S2) 0.65 0.68 0.66 0.67
Support 3 (S3) 0.62 0.65 0.66
Support 4 (S4) 0.64